Effects of PARP inhibition on drug and fas-induced apoptosis in leukaemic cells

Advances in Experimental Medicine and Biology

Volumn 457, Issue , 1999, Pages 267-279

  Richardson, Deborah S ^a,b   Allen, Paul D ^a,b   Kelsey, Stephen M ^a,b   Newland, Adrian C ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOBENZAMIDE; 3-AMINOBENZAMIDE; ANTINEOPLASTIC AGENT; BENZAMIDE DERIVATIVE; DRUG DERIVATIVE; ENZYME INHIBITOR; ETOPOSIDE; FAS ANTIGEN; FLUDARABINE; IDARUBICIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHENANTHRENE DERIVATIVE; PHENANTHRIDONE; VIDARABINE; VINBLASTINE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL STRAIN HL 60; DRUG ANTAGONISM; DRUG EFFECT; GENE; HUMAN; MICROTUBULE; MULTIDRUG RESISTANCE; PHYSIOLOGY; T CELL LEUKEMIA;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZAMIDES; DRUG RESISTANCE, MULTIPLE; ENZYME INHIBITORS; ETOPOSIDE; GENES, MDR; HL-60 CELLS; HUMANS; IDARUBICIN; LEUKEMIA, T-CELL, ACUTE; MICROTUBULES; PHENANTHRENES; POLY(ADP-RIBOSE) POLYMERASES; TUMOR CELLS, CULTURED; VIDARABINE; VINBLASTINE;

EID: 0032619318     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4811-9_29     Document Type: Article

References (59)

1. Sugimura T, Miwa M. Poly(ADP-ribose): historical perspective. Mol Cell Biochem. 1994, 138,5-12.
2. Brochu G, Duchaine C, Thibeault L, Lagueux J, Shah GM, Poirier GG. Mode of action of poly(ADP-ribose) glycohydrolase. Biochim Biophys Acta. 1994, 1219(2),342-50.
3. Naegeli H, Loetscher P, Althaus FR. Poly ADP-ribosylation of proteins. Processivity of a post-translational modification. J Biol Chem. 1989,264(24), 14382-5.
4. Lindahl T, Satoh MS, Poirier GG, Klungland A. Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem Sci. 1995, 20(10),405-11.
5. de Murcia G, Schreiber V, Molinete M, Saulier B, Poch O, Masson M, Niedergang C, Menissierde Murcia J. Structure and function of poly(ADP-ribose) polymerase. Mol Cell Biochem. 1994, 138(1-2),l5-24.
6. Ikejima M, Noguchi S, Yamashita R, Ogura T, Sugimura T, Gill D, Miwa M. The zinc fingers of human poly(ADP-ribose) polymerase are differentially required for the recognition of DNA breaks and nicks and the consequent enzyme activation. J Biol Chem. 1990, 265(35),21907-21913.
7. Buki KG, Bauer PI, Hakam A, Run E. Identification of domains of poly(ADP-ribose) polymerase for protein binding and self-association. J Biol Chem. 1995, 270(7),3370-7.
8. Simonin F, Poch O, Delarue M, de Murcia G. Identification of potential active-site residues in the human poly(ADP-ribose) polymerase. J Biol Chem. 1993, 268(12),8529-35.
9. Shall S. The function of poly(ADP-ribosylation) in DNA breakage and rejoining. Mol Cell Biochem. 1994, 138,71-75.
10. Satoh MS, Poirier GG, Lindahl T. Dual function for poly(ADP-ribose) synthesis in response to DNA strand breakage. Biochemistry. 1994, 33(23),7099-106.
11. de Murcia G, Menissier de Murcia J. Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem Sci. 1994, 19(4), 172-6.
12. Berger NA. Poly(ADP-ribose) in the cellular response to DNA damage. Radiation Res. 1985, 101(1),4-15.
13. Cleaver J, Morgan W. Poly(ADP-ribose)polymerase: a perplexing participant in cellular responses to DNA breakage. Mutation Res. 1991, 257,1-18.
14. Bramson J, Prévost J, Malapetsa A, Noë A, Poirier G, DesNoyers S, Alaoui-Jamali M, Panasci L. Poly(ADP-ribose) polymerase can bind melphalan damaged DNA. Cancer Res. 1993, 53,5370-5373.
15. Smulson M, Schein P, Mullins D, Sudhakar S. A putative role for nicotinamide adenine dinucleotide-promoted nuclear protein modificaton in the antitumour activity of N-methyl-N-nitrosurea. Cancer Res 1977, 37,3006-3012.
16. Creissen D, Shall S. Regulation of DNA ligase activity by poly(ADP-ribose). Nature. 1982, 296(271-272).
17. Purnell M, Whish W. Novel inhibitors of Poly(ADP-ribose) synthetase. Biochem J. 1980, 185,775-777.
18. Rankin P, Jacobson E, Benjamin R, Moss J, Jacobson M. Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo. J Biol Chem. 1989, 264(8),4312-4317.
19. Banasik M, Komura H, Shimoyama M, Ueda K. Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl) transferase. J Biol Chem. 1992, 267(3), 1569-1575.
20. Sestili P, Spadoni G, Balsamini C, Scovassi I, Cattabeni F, Duranti E, Cantoni O, Higgins D, Thomson C. Structural requirements for inhibitors of poly(ADP-ribose) polymerase. J Cancer Res Clin Oncol. 1990, 116,615-622.
21. Durkacz BW, Omidiji O, Gray DA, Shall S. (ADP-ribose)n participates in DNA excision repair. Nature. 1980, 283(5747),593-6.
22. Ding R, Pommier Y, Kang V, Smulson M. Depletion of poly(ADP-ribose) polymerase by antisense RNA expression results in a delay in DNA strand break rejoining. J Biol Chem. 1991, 267( 18), 12804-12812.
23. Satoh MS, Lindahl T. Role of poly(ADP-ribose) formation in DNA repair. Nature. 1992, 356(6367),356-8.
24. Nduka N, Skidmore J, Shall S. The enhancement of cytotoxicity of N-methyl-N-nitrosurea and of Y-radiation by inhibitors of poly(ADP-ribose) polymerase. Eur J Biochem. 1980, 105,525-530.
25. Brown D, Horsman M, Hirst D, Brown J. Enhancement of melphalan cytotoxicity in vivo and in vitro by inhibitors of poly (ADP-ribose) polymers. Int J Radiation Oncology. 1984, 10,1665-1668.
26. August E, Cooper D, Prusoff W. Inhibition of poly(adenosine diphosphate-ribose) polymerase by thymidine and thymidine analogues in L1210 cells and its relationship to the potentiation of the antitumour activity of l,3-bis(2-chloroethyl)-l-nitrosurea but not of 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine. Cancer Res. 1991, 51,1586-1590.
27. Boulton S, Pemberton L, Porteous J, Curtin N, Griffin R, Golding B, Durkacz B. Potentiation of temozolomide-induced cytotoxicity: a comparative study of the biological effects of poly(ADP-ribose) polymerase inhibitors. Br J Cancer. 1995, 1995(72),849-856.
28. Sebolt-Leopold J, Scavone S. Enhancement of alkylating agent activity in vitro by PD 128763, a potent poIy(ADP-ribose) synthetase inhibitor. Int J Radiation Oncology Biol Phys. 1992, 22,619-621.
29. Huet J, Laval F. Potentiation of cell killing by inhibitors of poly(adenosine diphosphate-ribose) synthesis in bleomycin-treated Chinese hamster ovary cells. Cancer Res. 1985, 45(3),987-91.
30. Hoshino J, Koeppel C, Westhäuser E. 3-aminobenzamide enhances dexamethasone-mediated mouse thymocyte depletion in vivo: implication for a role of poly ADP-rbosylation in the negative selection of immature thymocytes. Biochim Biophys Acta. 1994, 1201,516-522.
31. Witmer M, Aboul-Ela N, Jacobson M, Stamato T. Increased sensitivity to DNA-alkylating agents in CHO mutants with decreased poly(ADP-ribose) polymerase activity. Mutation Res. 1994, 314,249-260.
32. Judson I, Threadgill M. Poly(ADP-ribosylation) as target for cancer chemotherapy. Lancet. 1993, 342(8872),632.
33. Griffin RJ, Curtin NJ, Newell DR, Golding BT, Durkacz BW, Calvert AH. The role of inhibitors of poly(ADP-ribose) polymerase as resistance-modifying agents in cancer therapy. Biochimie. 1995, 77(6),408-22.
34. Beck WT, Mueller TJ, Tanzer LR. Altered surface membrane glycoproteins in vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res. 1979, 39(6),2070-6.
35. Kartner N, Riordan JR, Ling V. Cell surface p-glycoprotein is associated with multidrug resistance in mammalian cell lines. Science. 1983, 221,1285-8.
36. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry. 1992, 13,795-808.
37. Tanizawa A, Kubota M, Takimoto T, Akiyama Y, Seto S, Kiriyama Y, Mikawa H. Prevention of adriamycin-induced interphase death by 3-aminobenzamide and nicotinamide in a human promyelocytic leukemia cell line. Biochem Biophys Res Commun. 1987, 144(2),1031-1036.
38. Farzaneh F, Feon S, Lebby R, Brill D, David J-C, Shall S. DNA repair in human promyelocytic cell line, HL-60. Nucleic Acids Res. 1987, 15(8),3503-3513.
39. Kubota M, Tanizawa A, Hashimoto H, Shimizu T, Takimoto T, Kitoh T, Akiyama Y, Mikawa H. Cell type dependent activation of poly (ADP-ribose) synthesis following treatment with etoposide. Leuk Res. 1990, 14(4),37l-5.
40. Tanaka Y, Yoshihara K, Tohno Y, Kojima K, Kameoka M, Kamiya T. Inhibition and down-regulation of poly(ADP-ribose) polymerase results in a marked resistance of HL-60 cells to various apoptosis-inducers. Cell Mol Biol (Noisy-Le-Grand). 1995, 41(6),771-81.
41. Milam KM, Cleaver JE. Inhibitors of poly(adenosine diphosphate-ribose) synthesis: effect on other metabolic processes. Science. 1984, 223(4636),589-91.
42. Weltin D, Picard V, Aupeix K, Varin M, Oth D, Marchai J, Dufour P, Bischoff P. Immunosuppressive activities of 6(5H)-phenanthridinone, a new poly(ADP-ribose)polymerase inhibitor. Int J Immunopharmacol. 1995, 17(4),265-71.
43. Weltin D, Marchai J, Dufour P, Potworowski E, Oth D, Bischoff P. Effect of 6(5H)-phenanthridinone, an inhibitor of poly(ADP-ribose) polymerase, on cultured tumor cells. Oncol Res. 1994, 6(9),399-403.
44. Tanizawa A, Kubota M, Hashimoto H, Shimizu T, Takimoto T, Kitoh T, Akiyama Y, Mikawa H. VP-16-induced nucleotide pool changes and poly(ADP-ribose) synthesis: the role of VP-16 in interphase death. Exp Cell Res. 1989, 185(1),237-16.
45. Martin DS, Schwartz GK. Chemotherapeutically induced DNA damage, ATP depletion, and the apoptotic biochemical cascade. Oncol Res. 1997, 9( I ), 1-5.
46. Wright S, Wei Q, Kinder D, Larrick J. Biochemical pathways of apoptosis: nicotinamide adenine dinucleotide-deficient cells are resistant to tumour necrosis factor or ultraviolet light activation of the 24-kD apoptotic protease ans DNA fragmentation. J Exp Med. 1996, 183,463-471.
47. Wang ZQ, Auer B, Stingl L, Berghammer H, Haidacher D, Schweiger M, Wagner EF. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev. 1995, 9(5),509-20.
48. Leist M, Single B, Kunstle G, Volbracht C, Hentze H, Nicotera P. Apoptosis in the absence of poly-(ADPribose) polymerase. Biochem Biophys Res Commun. 1997, 233(2),5l8-22.
49. de Murcia JM, Niedergang C, Trucco C, Ricoul M, Dutrillaux B, Mark M, Oliver FJ, Masson M, Dierich A, LeMeur M, Walztinger C, Chambon P, de Murcia G. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci USA. 1997, 94( 14),7303-7.
50. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poIy(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 1993, 53(17),3976-85.
51. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Eamshaw WC. Cleavage of poIy(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 1994, 371(6495),346-7.
52. Schlegel J, Peters I, Orrenius S, Miller DK, Thornberry NA, Yamin TT, Nicholson DW. CPP32/apopain is a key interleukin I beta converting enzyme-like protease involved in Fas-mediated apoptosis. J Biol Chem. 1996, 271(4), 1841-4.
53. Tewari M. Quan LT, K OR, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 1995, 81(5),80l-9.
54. Nicholson DW, AH A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis [see comments]. Nature. 1995, 376(6535),37-43.
55. Casciola-Rosen L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK, Rosen A. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med. 1996, 183(5),1957-64.
56. Rosenthal DS, Ding R, Simbulan-Rosenthal CM, Vaillancourt JP, Nicholson DW, Smulson M. Intact cell evidence for the early synthesis, and subsequent late apopain-mediated suppression, of poly(ADP-ribose) during apoptosis. Exp Cell Res. 1997, 232(2),313-21.
57. Whitacre CM, Hashimoto H, Tsai ML, Chatterjee S, Berger SJ, Berger NA. Involvement of NADpoIy(ADP-ribose) metabolism in p53 regulation and its consequences. Cancer Res. 1995, 55(17),3697-701.
58. Wolf D, Rotter V. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sci USA. 1985, 82,790-794.
59. Masutani M, Nozaki T, Wakabayashi K, Sugimura T. Role of poly(ADP-ribose) polymerase in cell-cycle checkpoint mechanisms following gamma-irradiation. Biochimie. 1995, 77(6),462-5.